Barinthus Biotherapeutics's total assets for Q1 2025 were $142.00M, a decrease of -11.43% from the previous quarter. BRNS total liabilities were $26.40M for the fiscal quarter, a -12.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.